ROS-modulated therapeutic approaches in cancer treatment

Journal of Cancer Research and Clinical Oncology

Volumn 143, Issue 9, 2017, Pages 1789-1809

  Raza, Muhammad Hassan ^a   Siraj, Sami ^b   Arshad, Abida ^c   Waheed, Usman ^d   Aldakheel, Fahad ^e   Alduraywish, Shatha ^f   Arshad, Muhammad ^a  

^a INTERNATIONAL ISLAMIC UNIVERSITY   (Pakistan)

^b KHYBER MEDICAL UNIVERSITY   (Pakistan)

^c PMAS ARID AGRICULTURE UNIVERSITY   (Pakistan)

^d SHAHEED ZULFIQAR ALI BHUTTO MEDICAL UNIVERSITY   (Pakistan)

^e KING SAUD UNIVERSITY   (Saudi Arabia)

^f KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Antioxidants; Cancer therapy; Microbiota; Pro oxidants; Reactive oxygen species

Indexed keywords

ANTIOXIDANT; CYTOKINE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; GROWTH FACTOR; HYDROGEN PEROXIDE; HYDROXYL RADICAL; NITROXIDE DERIVATIVE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE;

ANGIOGENESIS; APOPTOSIS; AUTOPHAGY; CANCER CELL; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RESISTANCE; CANCER THERAPY; CARCINOGENESIS; DETOXIFICATION; DIETARY INTAKE; DNA DAMAGE; DRUG RESISTANCE; ENZYME INHIBITION; HUMAN; MALIGNANT NEOPLASM; MEDLINE; METASTASIS; MICROFLORA; MOLECULAR BIOLOGY; OXIDATIVE STRESS; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN TARGETING; RANDOMIZED CONTROLLED TRIAL (TOPIC); REGULATORY MECHANISM; REVIEW; TUMOR GROWTH; WEB OF SCIENCE; ANIMAL; NEOPLASM;

ANIMALS; HUMANS; NEOPLASMS; REACTIVE OXYGEN SPECIES;

EID: 85021241132     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-017-2464-9     Document Type: Review

References (208)

1. Agarwala SS, Sabbagh MH (2001) Histamine dihydrochloride: inhibiting oxidants and synergising IL-2-mediated immune activation in the tumour microenvironment. Expert Opin Biol Ther 1:869–879
2. Al-Abdullah ES, Al-Tuwaijri HM, Hassan HM, Al-Alshaikh MA, Habib EE, El-Emam AA (2015) Synthesis, antimicrobial and hypoglycemic activities of novel N-(1-adamantyl) carbothioamide derivatives. Molecules 20:8125–8143
3. Albanes D et al (2014) Plasma tocopherols and risk of prostate cancer in the Selenium and Vitamin E Cancer Prevention Trial (SELECT). Cancer Prev Res 7(9):886–895
4. Alexandre J, Nicco C, Chereau C, Laurent A, Weill B, Goldwasser F, Batteux F (2006) Improvement of the therapeutic index of anticancer drugs by the superoxide dismutase mimic mangafodipir. J Natl Cancer Inst 98(4):236–244
5. Al-Mayah A et al (2015) The non-targeted effects of radiation are perpetuated by exosomes. Mutat Res Fundam Mol Mech Mutagen 772:38–45
6. Altenhöfer S, Radermacher KA, Kleikers PW, Wingler K, Schmidt HH (2015) Evolution of NADPH oxidase inhibitors: selectivity and mechanisms for target engagement. Antioxid Redox Signal 23:406–427
7. Aunoble B, Sanches R, Didier E, Bignon Y (2000) Major oncogenes and tumor suppressor genes involved in epithelial ovarian cancer (review). Int J Oncol 16:567–576
8. Babior BM (1999) NADPH oxidase: an update. Blood 93:1464–1476
9. 2 production requires the activation of phosphatidylinositol 3-kinase. J Biol Chem 275:10527–10531
10. Bauer G (2012) Tumor cell-protective catalase as a novel target for rational therapeutic approaches based on specific intercellular ROS signaling. Anticancer Res 32:2599–2624
11. Belfi CA, Chatterjee S, Gosky DM, Berger SJ, Berger NA (1999) Increased sensitivity of human colon cancer Cells to DNA cross-linking agents after GRP78 up-regulation. Biochem Biophys Res Comm 257(2):361–368
12. Benhar M, Engelberg D, Levitzki A (2002) ROS, stress-activated kinases and stress signaling in cancer. EMBO Rep 3:420–425
13. Bey EA, Bentle MS, Reinicke KE, Dong Y, Yang C-R, Girard L, Minna JD, Bornmann WG, Gao J, Boothman DA (2007) An NQO1- and PARP-1-mediated cell death pathway induced in non-small-cell lung cancer cells by beta-lapachone. Proc Natl Acad Sci 104(28):11832–11837
14. Biaglow JE, Miller RA (2005) The thioredoxin reductase/thioredoxin system: novel redox targets for cancer therapy. Cancer Biol Ther 4:13–20
15. Bianchini F, Vainio H (2003) Wine and resveratrol: mechanisms of cancer prevention? Eur J Cancer Prev 12:417–425
16. Bienert GP, Møller AL, Kristiansen KA, Schulz A, Møller IM, Schjoerring JK, Jahn TP (2007) Specific aquaporins facilitate the diffusion of hydrogen peroxide across membranes. J Biol Chem 282:1183–1192
17. Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C (2007) Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA 297:842–857
18. Boyacioglu M et al (2014) The protective effects of vitamin C on the DNA damage, antioxidant defenses and aorta histopathology in chronic hyperhomocysteinemia induced rats. Exp Toxicol Pathol 66:407–413
19. Boyer-Guittaut M et al (2014) The role of GABARAPL1/GEC1 in autophagic flux and mitochondrial quality control in MDA-MB-436 breast cancer cells. Autophagy 10:986–1003
20. Brenner C, Pervaiz S, Clément M, Le Bras M (2005) Reactive oxygen species and the mitochondrial signaling pathway of cell death. Histol Histopathol 20:205–219
21. Buytaert E, Dewaele M, Agostinis P (2007) Molecular effectors of multiple cell death pathways initiated by photodynamic therapy. Biochim Biophys Acta (BBA) Rev Cancer 1776:86–107
22. Cai J et al (2008) Emodin-induced generation of reactive oxygen species inhibits RhoA activation to sensitize gastric carcinoma cells to anoikis. Neoplasia 10(1):41–51
23. Cardenas E, Ghosh R (2013) Vitamin E: a dark horse at the crossroad of cancer management. Biochem Pharmacol 86:845–852
24. Carlberg I, Mannervik B (1975) Purification and characterization of the flavoenzyme glutathione reductase from rat liver. J Biol Chem 250:5475–5480
25. Chan DW, Liu VW, Tsao GS, Yao K-M, Furukawa T, Chan KK, Ngan HY (2008) Loss of MKP3 mediated by oxidative stress enhances tumorigenicity and chemoresistance of ovarian cancer cells. Carcinogenesis 29:1742–1750
26. Chen J (2014) Reactive oxygen species and drug resistance in cancer chemotherapy. Austin J Clin Pathol 1:1017
27. Chen Q, Olashaw N, Wu J (1995) Participation of reactive oxygen species in the lysophosphatidic acid-stimulated mitogen-activated protein kinase kinase activation pathway. J Biol Chem 270:28499–28502
28. Chen J, Adikari M, Pallai R, Parekh HK, Simpkins H (2008) Dihydrodiol dehydrogenases regulate the generation of reactive oxygen species and the development of cisplatin resistance in human ovarian carcinoma cells. Cancer Chemother Pharmacol 61:979–987
29. Chen Z, Pittman EF, Romaguera J, Fayad L, Wang M, Neelapu SS, McLaughlin P, Kwak L, McCarty N (2013) Nuclear translocation of B-cell-specific transcription factor, BACH2, modulates ROS mediated cytotoxic responses in mantle cell lymphoma. PLoS One 8(8):e69126
30. Chiarugi P (2005) Review PTPs versus PTKs: the redox side of the coin. Free Radic Res 39:353–364
31. Chou W-C, Jie C, Kenedy AA, Jones RJ, Trush MA, Dang CV (2004) Role of NADPH oxidase in arsenic-induced reactive oxygen species formation and cytotoxicity in myeloid leukemia cells. Proc Natl Acad Sci USA 101:4578–4583
32. Clerkin J, Naughton R, Quiney C, Cotter T (2008) Mechanisms of ROS modulated cell survival during carcinogenesis. Cancer Lett 266:30–36
33. Combs F Jr (2015) Biomarkers of selenium status. Nutrients 7:2209–2236
34. Conklin KA (2000) Dietary antioxidants during cancer chemotherapy: impact on chemotherapeutic effectiveness and development of side effects. Nutr Cancer 37:1–18
35. Cornelis MC et al (2014) Genome-wide association study of selenium concentrations. Hum Mol Genet 24(5):1469–1477
36. Costello EK, Stagaman K, Dethlefsen L, Bohannan BJM, Relman DA (2012) The application of ecological theory toward an understanding of the human microbiome. Science 336:1255–1262. doi:10.1126/science.1224203
37. Crompton M (1999) The mitochondrial permeability transition pore and its role in cell death. Biochem J 341:233–249
38. Dai J, Weinberg RS, Waxman S, Jing Y (1999) Malignant cells can be sensitized to undergo growth inhibition and apoptosis by arsenic trioxide through modulation of the glutathione redox system. Blood 93:268–277
39. D’Andrea GM (2005) Use of antioxidants during chemotherapy and radiotherapy should be avoided. CA Cancer J Clin 55:319–321
40. Dansen TB, Wirtz KW (2001) The peroxisome in oxidative stress. IUBMB Life 51:223–230
41. Dasari S, Tchounwou PB (2014) Cisplatin in cancer therapy: molecular mechanisms of action. Eur J Pharmacol 740:364–378
42. D’Autréaux B, Toledano MB (2007) ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis. Nat Rev Mol Cell Biol 8:813–824
43. Denmeade SR, Mhaka AM, Rosen DM, Brennen WN, Dalrymple S, Dach I, Olesen C, Gurel B, DeMarzo AM, Wilding G, Carducci MA, Dionne CA, Moller JV, Nissen P, Christensen SB, Isaacs JT (2012) Engineering a prostate-specific membrane antigen-activated tumor endothelial cell prodrug for cancer therapy. Sci Transl Med 4(140):140ra86
44. Derick H, Williams E, Cadenas E (2001) Mitochondrial respiratory chain-dependent generation of superoxide anion and its release into the intermembrane space. Biochem J 353:411–416
45. Díaz-Laviada I, Rodríguez-Henche N (2014) The potential antitumor effects of capsaicin. In: Capsaicin as a Therapeutic Molecule. Springer Basel, pp 181–208
46. Dufour E, Gay F, Aguera K, Scoazec J-Y, Horand F, Lorenzi PL, Godfrin Y (2012) Pancreatic tumor sensitivity to plasma L-asparagine starvation. Pancreas 41:940–948
47. Dzutsev A, Goldszmid RS, Viaud S, Zitvogel L, Trinchieri G (2015) The role of the microbiota in inflammation, carcinogenesis, and cancer therapy. Eur J Immunol 45:17–31
48. Engel RH, Evens AM (2005) Oxidative stress and apoptosis: a new treatment paradigm in cancer. Front Biosci J Virtual Libr 11:300–312
49. Ermolaeva MA et al (2013) DNA damage in germ cells induces an innate immune response that triggers systemic stress resistance. Nature 501:416–420
50. Ferraro D et al (2006) Pro-metastatic signaling by c-Met through RAC-1 and reactive oxygen species (ROS). Oncogene 25:3689–3698
51. Fidias P, Novello S (2010) Strategies for prolonged therapy in patients with advanced non-small-cell lung cancer. J Clin Oncol 28:5116–5123
52. Fruehauf JP, Meyskens FL (2007) Reactive oxygen species: a breath of life or death? Clin Cancer Res 13:789–794
53. Galluzzi L et al (2014) Systems biology of cisplatin resistance: past, present and future. Cell Death Dis 5:e1257
54. Ghavami S et al (2008) Brevinin-2R1 semi-selectively kills cancer cells by a distinct mechanism, which involves the lysosomal-mitochondrial death pathway. J Cell Mol Med 12:1005–1022
55. Gianni D et al (2010) A novel and specific NADPH oxidase-1 (Nox1) small-molecule inhibitor blocks the formation of functional invadopodia in human colon cancer cells. ACS Chem Biol 5:981–993
56. Giles GI (2006) The redox regulation of thiol dependent signaling pathways in cancer. Curr Pharm Des 12:4427–4443
57. Gills JJ, LoPiccolo J, Tsurutani J, Shoemaker RH, Best CJM, Abu-Asab MS, Borojerdi J, Warfel NA, Gardner ER, Danish M, Hollander MC, Kawabata S, Tsokos M, Figg WD, Steeg PS, Dennis PA (2007) Nelfinavir, a lead HIV protease inhibitor, is a broad-spectrum, anticancer agent that induces endoplasmic reticulum stress, autophagy, and apoptosis in vitro and in vivo. Clin Cancer Res 13(17):5183–5194
58. Glasauer A, Chandel NS (2014) Targeting antioxidants for cancer therapy. Biochem Pharmacol 92:90–101
59. Glasauer A, Sena LA, Diebold LP, Mazar AP, Chandel NS (2014) Targeting SOD1 reduces experimental non-small-cell lung cancer. J Clin Investig 124:117–128
60. Glorieux C, Calderon PB (2017) Catalase, a remarkable enzyme: targeting the oldest antioxidant enzyme to find a new cancer treatment approach. Biol Chem. doi:10.1515/hsz-2017-0131
61. Glorieux C, Dejeans N, Sid B, Beck R, Calderon PB, Verrax J (2011) Catalase overexpression in mammary cancer cells leads to a less aggressive phenotype and an altered response to chemotherapy. Biochem Pharmacol 82:1384–1390
62. Goldszmid RS, Dzutsev A, Viaud S, Zitvogel L, Restifo NP, Trinchieri G (2015) Microbiota modulation of myeloid cells in cancer therapy. Cancer Immunol Res 3:103–109
63. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW (1994) Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 74:1141–1148
64. Gui Q, Lu H, Zhang C, Xu Z, Yang Y (2015) Well-balanced commensal microbiota contributes to anti-cancer response in a lung cancer mouse model. Genet Mol Res 14:5642–5651
65. Halliwell B (2007) Oxidative stress and cancer: have we moved forward? Biochem J 401:1–11
66. Hayes JD, Flanagan JU, Jowsey IR (2005) Glutathione transferases. Annu Rev Pharmacol Toxicol 45:51–88
67. Hellstrand K (2002) Histamine in cancer immunotherapy: a preclinical background. In: Seminars in oncology. vol 29, No. 3. WB Saunders, pp 35–40
68. Hierro C, Monte MJ, Lozano E, Gonzalez-Sanchez E, Marin JJ, Macias RI (2014) Liver metabolic/oxidative stress induces hepatic and extrahepatic changes in the expression of the vitamin C transporters SVCT1 and SVCT2. Eur J Nutr 53:401–412
69. Ho WJ et al (2015) Antioxidant micronutrients and the risk of renal cell carcinoma in the Women’s Health Initiative cohort. Cancer 121:580–588
70. Holmgren A (1995) Thioredoxin structure and mechanism: conformational changes on oxidation of the active-site sulfhydryls to a disulfide. Structure 3:239–243
71. Hong MY, Turner ND, Carroll RJ, Chapkin RS, Lupton JR (2005) Differential response to DNA damage may explain different cancer susceptibility between small and large intestine. Expe Biol Med 230:464–471
72. ® determines the death phenotype of human epidermoid carcinoma A431 cells triggered by photodynamic therapy: when plasma membranes are the main targets. J Cell Physiol 194:363–375
73. Hu B et al (2016) The DNA-sensing AIM2 inflammasome controls radiation-induced cell death and tissue injury. Science 354:765–768
74. Huang P, Feng L, Oldham EA, Keating MJ, Plunkett W (2000) Superoxide dismutase as a target for the selective killing of cancer cells. Nature 407:390–395
75. Hurst R et al (2012) Selenium and prostate cancer: systematic review and meta-analysis. Am J Clin Nutr 96:111–122
76. Hyoudou K, Nishikawa M, Kobayashi Y, Umeyama Y, Yamashita F, Hashida M (2006) PEGylated catalase prevents metastatic tumor growth aggravated by tumor removal. Free Radic Biol Med 41:1449–1458
77. Hyoudou K, Nishikawa M, Kobayashi Y, Ikemura M, Yamashita F, Hashida M (2008) SOD derivatives prevent metastatic tumor growth aggravated by tumor removal. Clin Exp Metastasis 25:531–536
78. Iida N et al (2013) Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment. Science 342:967–970
79. Ishikawa K et al (2008) ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis. Science 320:661–664
80. Ivanova D, Bakalova R, Lazarova D, Gadjeva V, Zhelev Z (2012) The impact of reactive oxygen species on anticancer therapeutic strategies. Adv Clin Exp Med Off Organ Wroclaw Med Univ 22:899–908
81. Jablonska E, Vinceti M (2015) Selenium and human health: witnessing a Copernican revolution? J Environ Sci Health Part C 33:328–368
82. Jaramillo MC, Zhang DD (2013) The emerging role of the Nrf2–Keap1 signaling pathway in cancer. Genes Dev 27:2179–2191
83. Jiang Q (2014) Natural forms of vitamin E: metabolism, antioxidant, and anti-inflammatory activities and their role in disease prevention and therapy. Free Radic Biol Med 72:76–90
84. Jing X, Ueki N, Cheng J, Imanishi H, Hada T (2002) Induction of apoptosis in hepatocellular carcinoma cell lines by emodin. Jpn J Cancer Res 93:874–882
85. Jing Y et al (2006) Alteration of subcellular redox equilibrium and the consequent oxidative modification of nuclear factor κB are critical for anticancer cytotoxicity by emodin, a reactive oxygen species-producing agent. Free Radic Biol Med 40:2183–2197
86. Jones RM et al (2013) Symbiotic lactobacilli stimulate gut epithelial proliferation via Nox-mediated generation of reactive oxygen species. EMBO J 32:3017–3028
87. Jones RM et al (2015) Lactobacilli modulate epithelial cytoprotection through the Nrf2 pathway. Cell Rep 12:1217–1225
88. Juarez JC, Manuia M, Burnett ME, Betancourt O, Boivin B, Shaw DE, Tonks NK, Mazar AP, Donate F (2008) Superoxide dismutase 1 (SOD1) is essential for H2O2-mediated oxidation and inactivation of phosphatases in growth factor signaling. Proc Natl Acad Sci 105(20):7147–7152
89. Kansanen E, Kuosmanen SM, Leinonen H, Levonen A-L (2013) The Keap1–Nrf2 pathway: mechanisms of activation and dysregulation in cancer. Redox Biol 1:45–49
90. Kim Y-S, Morgan MJ, Choksi S, Z-g Liu (2007) TNF-induced activation of the Nox1 NADPH oxidase and its role in the induction of necrotic cell death. Mol Cell 26:675–687
91. Kim Y, Wei J, Citronberg J, Hartman T, Fedirko V, Goodman M (2015) Relation of vitamin E and selenium exposure to prostate cancer risk by smoking status: a review and meta-analysis. Anticancer Res 35:4983–4996
92. Kirshner JR, He S, Balasubramanyam V, Kepros J, Yang C-Y, Zhang M, Du Z, Barsoum J, Bertin J (2008) Elesclomol induces cancer cell apoptosis through oxidative stress. Mol Can Ther 7(8):2319–2327
93. Kizaki M, Xian M, Sagawa M, Ikeda Y (2006) Induction of apoptosis via the modulation of reactive oxygen species (ROS) production in the treatment of myeloid leukemia. Curr Pharm Biotechnol 7:323–329
94. Kong Q, Lillehei K (1998) Antioxidant inhibitors for cancer therapy. Med Hypotheses 51:405–409
95. Kontek R, Kontek B, Grzegorczyk K (2013) Vitamin C modulates DNA damage induced by hydrogen peroxide in human colorectal adenocarcinoma cell lines (HT29) estimated by comet assay in vitro. Arch Med Sci AMS 9:1006–1012
96. Kroemer G, Galluzzi L, Kepp O, Zitvogel L (2013) Immunogenic cell death in cancer therapy. Annu Rev Immunol 31:51–72
97. Kubo T, Shimose S, Matsuo T, Tanaka K, Yasunaga Y, Sakai A, Ochi M (2006) Inhibitory effects of a new bisphosphonate, minodronate, on proliferation and invasion of a variety of malignant bone tumor cells. J Orthop Res 24:1138–1144
98. Lai W-L, Wong N-S (2005) ROS mediates 4HPR-induced posttranscriptional expression of the Gadd153 gene. Free Radic Biol Med 38(12):1585–1593
99. Le A, Lane AN, Hamaker M, Bose S, Gouw A, Barbi J, Tsukamoto T, Rojas CJ, Slusher BS, Zhang H, Zimmerman LJ, Liebler DC, Slebos RJ, Lorkiewicz PK, Higashi RM, Fan TW, Dang CV (2012) Glucose-independent glutamine metabolism via TCA cycling for proliferation and survival in B Cells. Cell Metab 15(1):110–121
100. 2 regulates the activation of distinct MAPK pathways. Free Radic Biol Med 33:1121–1132
101. Lee W-K, Thévenod F (2006) A role for mitochondrial aquaporins in cellular life-and-death decisions? Am J Physiol Cell Physiol 291:C195–C202
102. Lee Y-J et al (2012) Reactive oxygen species and PI3K/Akt signaling play key roles in the induction of Nrf2-driven heme oxygenase-1 expression in sulforaphane-treated human mesothelioma MSTO-211H cells. Food Chem Toxicol 50:116–123
103. Li X, Yin D, Yin J, Chen Q, Wang R (2014) Dietary selenium protect against redox-mediated immune suppression induced by methylmercury exposure. Food Chem Toxicol 72:169–177
104. Li Y et al (2015) Effects of vitamin E from supplements and diet on colonic α-and γ-tocopherol concentrations in persons at increased colon cancer risk. Nutr Cancer 67:73–81
105. Lim SD et al (2005) Increased Nox1 and hydrogen peroxide in prostate cancer. Prostate 62:200–207
106. Liu Y, Min W (2002) Thioredoxin promotes ASK1 ubiquitination and degradation to inhibit ASK1-mediated apoptosis in a redox activity-independent manner. Circ Res 90:1259–1266
107. Liu J, Du J, Zhang Y, Sun W, Smith BJ, Oberley LW, Cullen JJ (2006) Suppression of the malignant phenotype in pancreatic cancer by overexpression of phospholipid hydroperoxide glutathione peroxidase. Hum Gene Ther 17:105–116
108. Liu Y-Q et al (2013) Synthesis and mechanistic studies of novel spin-labeled combretastatin derivatives as potential antineoplastic agents. Bioorg Med Chem 21:1248–1256
109. Lo YY, Cruz TF (1995) Involvement of reactive oxygen species in cytokine and growth factor induction of c-fos expression in chondrocytes. J Biol Chem 270:11727–11730
110. Lo M, Ling V, Low C, Wang YZ, Gout PW (2010) Potential use of the anti-inflammatory drug, sulfasalazine, for targeted therapy of pancreatic cancer. Current Oncol 17:9–16
111. Lum GB, Shelp BJ, DeEll JR, Bozzo GG (2016) Oxidative metabolism is associated with physiological disorders in fruits stored under multiple environmental stresses. Plant Sci 245:143–152
112. Madesh M, Hajnóczky G (2001) VDAC-dependent permeabilization of the outer mitochondrial membrane by superoxide induces rapid and massive cytochrome c release. J Cell Biol 155:1003–1016
113. Maeda H, Hori S, Ohizumi H, Segawa T, Kakehi Y, Ogawa O, Kakizuka A (2004) Effective treatment of advanced solid tumors by the combination of arsenic trioxide and L-buthionine-sulfoximine. Cell Death Differ 11:737–746
114. Magda D, Miller RA (2006) Motexafin gadolinium: a novel redox active drug for cancer therapy. Semin Cancer Biol 16(6):466–476
115. Maier I, Berry DM, Schiestl RH (2014) Intestinal microbiota reduces genotoxic endpoints induced by high-energy protons. Radiat Res 181:45–53
116. Mavragani IV, Laskaratou DA, Frey B, Candéias SM, Gaipl US, Lumniczky K, Georgakilas AG (2016) Key mechanisms involved in ionizing radiation-induced systemic effects. Curr Rev Toxicol Res 5:12–33
117. Mazdak H, Zia H (2012) Vitamin E reduces superficial bladder cancer recurrence: a randomized controlled trial. Int J Prev Med 3(2):110–115
118. Medan D et al (2005) Regulation of Fas (CD95)-induced apoptotic and necrotic cell death by reactive oxygen species in macrophages. J Cell Physiol 203:78–84
119. Meier B, Radeke H, Selle S, Younes M, Sies H, Resch K, Habermehl G (1989) Human fibroblasts release reactive oxygen species in response to interleukin-1 or tumour necrosis factor-α. Biochem J 263:539–545
120. Meng T-C, Fukada T, Tonks NK (2002) Reversible oxidation and inactivation of protein tyrosine phosphatases in vivo. Mol Cell 9:387–399
121. Minamoto T, Mai M, Ze Ronai (1999) K-ras mutation: early detection in molecular diagnosis and risk assessment of colorectal, pancreas, and lung cancers—a review. Cancer Detect Prev 24:1–12
122. Minamoto T, Ougolkov AV, Mai M (2002) Detection of oncogenes in the diagnosis of cancers with active oncogenic signaling. Expert Rev Mol Diagn 2:565–575
123. Minegaki T et al (2014) Genetic polymorphisms in SLC23A2 as predictive biomarkers of severe acute toxicities after treatment with a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma. Inte J Med Sci 11:321
124. Montero AJ, Jassem J (2011) Cellular redox pathways as a therapeutic target in the treatment of cancer. Drugs 71:1385–1396
125. Montero AJ, Diaz-Montero CM, Deutsch YE, Hurley J, Koniaris LG, Rumboldt T, Yasir S, Jorda M, Garret-Mayer E, Avisar E, Slingerland J, Silva O, Welsh C, Schuhwerk K, Seo P, Pegram MD, S. Glück S (2012) Phase 2 study of neoadjuvant treatment with NOV-002 in combination with doxorubicin and cyclophosphamide followed by docetaxel in patients with HER-2 negative clinical stage II-IIIc breast cancer. Breast Cancer Res Treat 132(1):215–223
126. Mookerjee A et al (2006) A novel copper complex induces ROS generation in doxorubicin resistant Ehrlich ascitis carcinoma cells and increases activity of antioxidant enzymes in vital organs in vivo. BMC Cancer 6:267
127. Mustacich D, Powis G (2000) Thioredoxin reductase. Biochem J 346:1–8
128. Nelson SK, Bose SK, Grunwald GK, Myhill P, McCord JM (2006) The induction of human superoxide dismutase and catalase in vivo: a fundamentally new approach to antioxidant therapy. Free Radic Biol Med 40:341–347
129. Neumann CA, Fang Q (2007) Are peroxiredoxins tumor suppressors? Curr Opin Pharmacol 7:375–380
130. Nikitaki Z et al (2016) Systemic mechanisms and effects of ionizing radiation: A new ‘old’ paradigm of how the bystanders and distant can become the players. Semin Cell Biol 37:77–95
131. Ohba M, Shibanuma M, Kuroki T, Nose K (1994) Production of hydrogen peroxide by transforming growth factor-beta 1 and its involvement in induction of egr-1 in mouse osteoblastic cells. J Cell Biol 126:1079–1088
132. Outzen M et al (2016) Selenium status and risk of prostate cancer in a Danish population. Br J Nutr 115:1669–1677
133. Ozben T (2007) Oxidative stress and apoptosis: impact on cancer therapy. J Pharm Sci 96:2181–2196
134. Padhye S et al (2012) Perspectives on medicinal properties of plumbagin and its analogs. Med Res Rev 32:1131–1158. doi:10.1002/med.20235
135. Papa L, Gomes E, Rockwell P (2007) Reactive oxygen species induced by proteasome inhibition in neuronal cells mediate mitochondrial dysfunction and a caspase-independent cell death. Apoptosis 12(8):1389–1405
136. Park SB et al (2013) Chemotherapy-induced peripheral neurotoxicity: a critical analysis. CA Cancer J Clin 63:419–437
137. Pateras IS et al (2015) The DNA damage response and immune signaling alliance: is it good or bad? Nature decides when and where. Pharmacol Ther 154:36–56
138. Pelicano H, Carney D, Huang P (2004) ROS stress in cancer cells and therapeutic implications. Drug Resist Updates 7:97–110
139. Perez-Chanona E, Trinchieri G (2016) The role of microbiota in cancer therapy. Curr Opin Immunol 39:75–81
140. Poillet-Perez L, Despouy G, Delage-Mourroux R, Boyer-Guittaut M (2015) Interplay between ROS and autophagy in cancer cells, from tumor initiation to cancer therapy. Redox Biol 4:184–192
141. Ravid T, Heidinger JM, Gee P, Khan EM, Goldkorn T (2004) c-Cbl-mediated ubiquitinylation is required for epidermal growth factor receptor exit from the early endosomes. J Biol Chem 279:37153–37162
142. Reid ME et al (2008) The nutritional prevention of cancer: 400 mcg per day selenium treatment. Nutr Cancer 60:155–163
143. Reinehr R, Becker S, Eberle A, Grether-Beck S, Häussinger D (2005) Involvement of NADPH oxidase isoforms and Src family kinases in CD95-dependent hepatocyte apoptosis. J Biol Chem 280:27179–27194
144. Ren D, Villeneuve NF, Jiang T, Wu T, Lau A, Toppin HA, Zhang DD (2011) Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism. Proc Natl Acad Sci 108:1433–1438
145. Renschler MF (2004) The emerging role of reactive oxygen species in cancer therapy. Eur J Cancer 40:1934–1940
146. Roy S, Trinchieri G (2017) Microbiota: a key orchestrator of cancer therapy. Nat Rev Cancer 17(5):271–285
147. Roy D, Sarkar S, Felty Q (2006) Levels of IL-1 beta control stimulatory/inhibitory growth of cancer cells. Front Biosci 11:889–898
148. Roy S, Ryals MM, Van den Bruele AB, Fitzgerald TS, Cunningham LL (2013) Sound preconditioning therapy inhibits ototoxic hearing loss in mice. J Clin Investig 123:4945–4949
149. Ryoo K, Huh S-H, Lee YH, Yoon KW, Cho S-G, Choi E-J (2004) Negative regulation of MEKK1-induced signaling by glutathione S-transferase Mu. J Biol Chem 279:43589–43594
150. Sancho-Martínez SM, Prieto-García L, Prieto M, López-Novoa JM, López-Hernández FJ (2012) Subcellular targets of cisplatin cytotoxicity: an integrated view. Pharmacol Ther 136:35–55
151. Sato K, Yuasa T, Nogawa M, Kimura S, Segawa H, Yokota A, Maekawa T (2006) A third-generation bisphosphonate, minodronic acid (YM529), successfully prevented the growth of bladder cancer in vitro and in vivo. Br J Cancer 95:1354–1361
152. Scherz-Shouval R, Elazar Z (2007) ROS, mitochondria and the regulation of autophagy. Trends Cell Biol 17:422–427
153. Scherz-Shouval R, Elazar Z (2011) Regulation of autophagy by ROS: physiology and pathology. Trends Biochem Sci 36:30–38
154. Scherz-Shouval R, Shvets E, Elazar Z (2007a) Oxidation as a post-translational modification that regulates autophagy. Autophagy 3:371–373
155. Scherz-Shouval R, Shvets E, Fass E, Shorer H, Gil L, Elazar Z (2007b) Reactive oxygen species are essential for autophagy and specifically regulate the activity of Atg4. EMBO J 26:1749–1760
156. Schildknecht S et al (2014) The NOX1/4 inhibitor GKT136901 as selective and direct scavenger of peroxynitrite. Curr Med Chem 21:365–376
157. Seifried HE, McDonald SS, Anderson DE, Greenwald P, Milner JA (2003) The antioxidant conundrum in cancer. Cancer Res 63:4295–4298
158. Seifried HE, Anderson DE, Fisher EI, Milner JA (2007) A review of the interaction among dietary antioxidants and reactive oxygen species. J Nutr Biochem 18:567–579
159. Sharma R, Yang Y, Sharma A, Awasthi S, Awasthi YC (2004) Antioxidant role of glutathione S-transferases: protection against oxidant toxicity and regulation of stress-mediated apoptosis. Antioxid Redox Signal 6:289–300
160. Shaw AT, Winslow MM, Magendantz M, Ouyang C, Dowdle J, Subramanian A, Lewis TA, Maglathin RL, Tolliday N, Jacks T (2011) Selective killing of K-ras mutant cancer cells by small molecule inducers of oxidative stress. Proc Natl Acad Sci 108(21):8773–8778
161. Shen B, He P-J, Shao C-L (2013) Norcantharidin induced DU145 cell apoptosis through ROS-mediated mitochondrial dysfunction and energy depletion. PLoS One 8:e84610
162. Shinozaki K, Hosokawa Y, Hazawa M, Kashiwakura I, Okumura K, Kaku T, Nakayama E (2011) Ascorbic acid enhances radiation-induced apoptosis in an HL60 human leukemia cell line. J Radiat Res 52:229–237
163. Siddiqui IA, Adhami VM, Saleem M, Mukhtar H (2006) Beneficial effects of tea and its polyphenols against prostate cancer. Mol Nutr Food Res 50:130–143
164. Šimůnek T, Stérba M, Popelová O, Adamcová M, Hrdina R, Gersl V (2009) Anthracycline-induced cardiotoxicity: Overview of studies examining the roles of oxidative stress and free cellular iron. Pharmacol Rep 61(1):154–171
165. Sies H, Berndt C, Jones DP (2017) Oxidative stress. Ann Rev Biochem doi:10.1146/annurev-biochem-061516-045037
166. Solban N, Rizvi I, Hasan T (2006) Targeted photodynamic therapy. Lasers Surg Med 38:522–531
167. Song JJ, Lee YJ (2003) Differential role of glutaredoxin and thioredoxin in metabolic oxidative stress-induced activation of apoptosis signal-regulating kinase 1. Biochem J 373:845
168. Soule BP et al (2007) The chemistry and biology of nitroxide compounds. Free Radic Biol Med 42:1632–1650
169. Stewart BW, Wild CP (2014) World Cancer Report 2014. IARC
170. Storz P (2005) Reactive oxygen species in tumor progression. Front Biosci 10:1881–1896
171. Sun J et al (2016) Synthesis of a novel adamantyl nitroxide derivative with potent anti-hepatoma activity in vitro and in vivo American. J Cancer Res 6:1271
172. 2 for platelet-derived growth factor signal transduction. Science 270:296
173. Suzuki-Karasaki Y, Suzuki-Karasaki M, Uchida M, Ochiai T (2014) Depolarization controls TRAIL-sensitization and tumor-selective killing of cancer cells: crosstalk with ROS. Front Oncol 4:128
174. Szatrowski TP, Nathan CF (1991) Production of large amounts of hydrogen peroxide by human tumor cells. Can Res 51:794–798
175. Takemura N et al (2014) Blockade of TLR3 protects mice from lethal radiation-induced gastrointestinal syndrome. Nat Commun 5:3492. doi:10.1038/ncomms4492
176. Tian X et al (2014) Bufalin loaded biotinylated chitosan nanoparticles: an efficient drug delivery system for targeted chemotherapy against breast carcinoma. Eur J Pharm Biopharm 87:445–453
177. Tiku M, Liesch J, Robertson F (1990) Production of hydrogen peroxide by rabbit articular chondrocytes. Enhancement by cytokines. J Immunol 145:690–696
178. Tobe R, Yoo M-H, Fradejas N, Carlson BA, Calvo S, Gladyshev VN, Hatfield DL (2012) Thioredoxin reductase 1 deficiency enhances selenite toxicity in cancer cells via a thioredoxin-independent mechanism. Biochem J 445:423–430
179. Toler SM, Noe D, Sharma A (2006) Selective enhancement of cellular oxidative stress by chloroquine: implications for the treatment of glioblastoma multiforme. Neurosurg Focus 21:1–4
180. Touchefeu Y et al (2014) Systematic review: the role of the gut microbiota in chemotherapy-or radiation-induced gastrointestinal mucositis—current evidence and potential clinical applications. Aliment Pharmacol Ther 40:409–421
181. Townsend DM, Tew KD (2003) The role of glutathione-S-transferase in anti-cancer drug resistance. Oncogene 22:7369
182. Trachootham D et al (2006) Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by β-phenylethyl isothiocyanate. Cancer Cell 10:241–252
183. Traverso N et al (2013) Role of glutathione in cancer progression and chemoresistance. Oxid Med Cell Longev 2013:972913. doi:10.1155/2013/972913
184. Uchikura K et al (2004) Lipopolysaccharides induced increases in Fas ligand expression by Kupffer cells via mechanisms dependent on reactive oxygen species. Am J Physiol Gastrointest Liver Physiol 287:G620–G626
185. Ushio-Fukai M, Nakamura Y (2008) Reactive oxygen species and angiogenesis: NADPH oxidase as target for cancer therapy. Cancer Lett 266:37–52
186. Vacchelli E, Eggermont A, Sautès-Fridman C, Galon J, Zitvogel L, Kroemer G, Galluzzi L (2013) Trial Watch: Toll-like receptor agonists for cancer therapy. Oncoimmunology 2:e25238
187. Venkataraman S et al (2005) Manganese superoxide dismutase overexpression inhibits the growth of androgen-independent prostate cancer cells. Oncogene 24:77–89
188. Wang J, Yi J (2008) Cancer cell killing via ROS: to increase or decrease, that is the question. Cancer Biol Ther 7:1875–1884
189. Wang X, Zhang J, Xu T (2007) Cyclophosphamide as a potent inhibitor of tumor thioredoxin reductase in vivo. Toxicol Appl Pharmacol 218:88–95
190. Wang Y et al (2015) Pharmacological inhibition of NADPH oxidase protects against cisplatin induced nephrotoxicity in mice by two step mechanism. Food Chem Toxicol 83:251–260
191. Weekley CM, Aitken JB, Finney L, Vogt S, Witting PK, Harris HH (2013) Selenium metabolism in cancer cells: the combined application of XAS and XFM techniques to the problem of selenium speciation in biological systems. Nutrients 5:1734–1756
192. Wright ME et al (2009) Genetic variation in sodium-dependent ascorbic acid transporters and risk of gastric cancer in Poland. Eur J Cancer 45:1824–1830
193. Wu X-J, Hua X (2007) Targeting ROS: selective killing of cancer cells by a cruciferous vegetable derived pro-oxidant compound. Cancer Biol Ther 6:646–647
194. Wu JH, Miao W, Hu LG, Batist G (2010) Identification and characterization of novel Nrf2 inducers designed to target the intervening region of Keap1. Chem Biol Drug Des 75:475–480
195. Wu X, Cheng J, Wang X (2017) Dietary antioxidants: potential anticancer agents. Nutr Cancer 69(4):521–533
196. Yamagishi S-I et al (2004) Minodronate, a newly developed nitrogen-containing bisphosphonate, suppresses melanoma growth and improves survival in nude mice by blocking vascular endothelial growth factor signaling. Am J Pathol 165:1865–1874
197. Yi J, Gao F, Shi G, Li H, Wang Z, Shi X, Tang X (2002) The inherent cellular level of reactive oxygen species: one of the mechanisms determining apoptotic susceptibility of leukemic cells to arsenic trioxide. Apoptosis 7:209–215
198. Yi J, Yang J, He R, Gao F, Sang H, Tang X, Richard DY (2004) Emodin enhances arsenic trioxide-induced apoptosis via generation of reactive oxygen species and inhibition of survival signaling. Can Res 64:108–116
199. Yoshida T et al (2017) Apocynin and enzymatically modified isoquercitrin suppress the expression of a NADPH oxidase subunit p22phox in steatosis-related preneoplastic liver foci of rats. Exp Toxicol Pathol 69:9–16
200. Yoshida T, Goto S, Kawakatsu M, Urata Y, Li T-S (2012) Mitochondrial dysfunction, a probable cause of persistent oxidative stress after exposure to ionizing radiation. Free Radic Res 46(2):147–153
201. Yours S, Liochev S, Fridovich I, Koppenol W (1999) The relative importance of ho and onoo-in mediating the toxicity of o-. Author’s reply. Free Radic Biol Med 26:777–778
202. Zhang L et al (2011) New insight into the Nox4 subcellular localization in HEK293 cells: first monoclonal antibodies against Nox4. Biochimie 93:457–468
203. Zhao X-B et al (2014) Design and synthesis of novel spin-labeled camptothecin derivatives as potent cytotoxic agents. Bioorg Med Chem 22:6453–6458
204. Zhu X, Wang K, Zhang K, Zhu L, Zhou F (2014) Ziyuglycoside II induces cell cycle arrest and apoptosis through activation of ROS/JNK pathway in human breast cancer cells. Toxicol Lett 227:65–73
205. Zhu X-H et al (2016) Synthesis, crystal structure, superoxide scavenging activity, anticancer and docking studies of novel adamantyl nitroxide derivatives. J Mol Struct 1108:611–617
206. Zhu S, Pabla N, Tang C, He L, Dong Z (2015) DNA damage response in cisplatin-induced nephrotoxicity. Arch Toxicol 89:2197–2205
207. Zhu J, Song X, Lin H-P, Young DC, Yan S, Marquez VE, Chen C-S (2002) Using cyclooxygenase-2 inhibitors as molecular platforms to develop a new class of apoptosis-inducing agents. J Natl Cancer Inst 94:1745–1757
208. Zitvogel L, Galluzzi L, Viaud S, Vétizou M, Daillère R, Merad M, Kroemer G (2015) Cancer and the gut microbiota: an unexpected link. Sci Transl Med 7(271):271ps1